checkAd

    $$Global Matrechs +133%%%% in Berlin!! - 500 Beiträge pro Seite

    eröffnet am 16.05.06 17:34:55 von
    neuester Beitrag 16.05.06 18:23:20 von
    Beiträge: 12
    ID: 1.060.462
    Aufrufe heute: 0
    Gesamt: 1.155
    Aktive User: 0


     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 16.05.06 17:34:55
      Beitrag Nr. 1 ()
      A0B64H
      handelbar in Berlin, FFM, und Amiland

      Totalverlustrisiko aber auch riesen Chance:D
      Avatar
      schrieb am 16.05.06 17:38:07
      Beitrag Nr. 2 ()
      :eek::eek::eek::eek::eek::eek::eek::eek::eek::eek::eek::eek::eek::eek:
      DIE NEWS DÜRFTE EINE NEUBEWERTUNG AUSLÖSEN!!!!!!!!!!!!!
      Global Matrechs, Inc. Announces Licensing Agreement for Radiation Resistant Technology Targeting Environmental and Nuclear Waste Markets in the European Community, China and India
      Global Matrechs, Inc. (OTCBB:GMTH) http://www.globalmatrechs.com, a company with technologies in the nuclear, chemical and environmental sectors, reports it has entered into a licensing agreement with NUCON-RF, Inc.,("NUCON"Zwinkern, http://www.nucon-rf.com, a US Corporation with executive and operations offices in Moscow, to market NuCap(TM). The agreement gives NUCON-RF exclusive distribution in the Former Soviet Union and non-exclusive rights in the European Union, China and India for NuCap(TM), a highly radiation- and corrosion-resistant technology.

      NUCON\'s expertise and focus is technical solutions for high-end environmental markets in the Former Soviet Union, Europe & Asia. NUCON has identified markets and demand for the cleaning up of nuclear waste and other markets for NuCap(TM) including the Chernobyl Shelter. The strategic alliances of NUCON-RF include ROSENERGOATOM ("ROSATOM"Zwinkern, the operating utility of all Russia\'s nuclear power plants and ATOMSTROYEXPORT ("ASE"Zwinkern. ASE was established by the Ministry of the Russian Federation for Atomic Energy, to promote the export of Russian-made products for nuclear power projects abroad.

      Under the terms, Global Matrechs, Inc. retains ownership and controls the worldwide exclusive proprietary rights to NuCap(TM), with manufacturing via Dow Corning. NUCON-RF has the sub-license rights to market, sell and distribute NuCap(TM) into the following territories; Russian Federation on an exclusive basis, European Union, China and India on a non-exclusive basis.

      According to CEO Michael Sheppard, "We have been working on this agreement for 18 months in order to execute delivery of NuCap(TM) into new foreign markets. We are thrilled to be associated with NUCON-RF and foresee the market penetration that was expected for the technology in the Eastern European markets years ago, to finally come to fruition."

      NuCap(TM) is engineered for use in a wide variety of applications in low to high level radiation and other environmentally challenging settings. NuCap(TM) applications range from in-situ stabilization, D & D, containment and encapsulation to transportation and final storage and disposal. NuCap(TM) can also assist in resolving the special challenges faced by operating reactors in nuclear power plants and research facilities, uranium/thorium and other mining venues, nuclear medicine and the chemical industry.

      About NUCON_RF http://www.nucon-rf.com/

      (OTC:SFDE.PK) Nucon has the capability to provide product, technological and engineering support for environmental and radioactive waste challenges including, compliance, shielding, transport and storage requirements for a broad range of radioactive and toxic wastes.

      About Global Matrechs: www.globalmatrechs.com

      Global Matrechs has operated its licensed technologies business since 2004. Global Matrechs seeks to convert the licenses it has acquired in emerging technologies in the nuclear energy, environmental and chemical industries into manufactured products primarily through sub-licenses of those technologies to manufacturers.

      "Forward-Looking Statements"

      Investors are cautioned that certain statements contained in this document, as well as other statements in periodic press releases and some oral statements of Global Matrechs, Inc. officials during presentations, are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"Zwinkern.

      Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, or which include words such as "expects", "anticipates", "intends", "plans", "believes", "estimates", "hopes," "seeks," or similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future actions, which may be provided by management, are also forward-looking statements as defined by the Act.

      Some of the factors that could significantly impact these forward-looking statements in this press release include, but are not limited to: insufficient cash flow to continue to fund the development and marketing of the Company\'s products and technologies; the failure of the Company\'s products and technologies to become commercially marketable; the loss of key personnel; changes in financial markets and general economic conditions; and, disputes as to the Company\'s intellectual property rights, including the Company\'s rights to the technologies that it licenses from Eurotech, Ltd. Forward-looking statements are based upon current expectations and projections about future events and are subject to risks, uncertainties, and assumptions about Global Matrechs, its licenses, products, economic and market factors and the sectors in which Global Matrechs does business, among other things. These statements are not guarantees of future performance and Global Matrechs has no specific intention to update these statements. More detailed information about those factors is contained in Global Matrechs\'s filings with the Securities and Exchange Commission.


      Global Matrechs, Inc.
      Michael Sheppard, 203-431-6665



      Source: Business Wire (May 16, 2006 - 9:27 AM EDT)

      News by QuoteMedia
      www.quotemedia.com
      Avatar
      schrieb am 16.05.06 17:40:38
      Beitrag Nr. 3 ()
      Frankfurt schon 0,008 :eek::eek::eek:
      Avatar
      schrieb am 16.05.06 17:43:07
      Beitrag Nr. 4 ()
      Antwort auf Beitrag Nr.: 21.608.832 von fortuna99 am 16.05.06 17:40:38Kaufen alle über Pari! :rolleyes::rolleyes:
      Avatar
      schrieb am 16.05.06 17:43:47
      Beitrag Nr. 5 ()
      in Frankfurt hat einer 1,3 MIllionen gekauft 17.33uhr:lick:

      Trading Spotlight

      Anzeige
      InnoCan Pharma
      0,1890EUR -1,82 %
      InnoCan Pharma: Q1 2024 Monster-Zahlen “ante portas”?!mehr zur Aktie »
      Avatar
      schrieb am 16.05.06 17:47:47
      Beitrag Nr. 6 ()
      Antwort auf Beitrag Nr.: 21.608.873 von OG_Broker am 16.05.06 17:43:07Ja,vielleicht weiß da einer mehr :rolleyes:
      Die Amis müßten jetzt mal zeigen wo der Weg hingeht.
      Avatar
      schrieb am 16.05.06 17:48:09
      Beitrag Nr. 7 ()
      Antwort auf Beitrag Nr.: 21.608.886 von StefanBroker am 16.05.06 17:43:47der hat recht und das geld gehabt;)
      Avatar
      schrieb am 16.05.06 17:54:05
      Beitrag Nr. 8 ()
      Sind mittlerweile leider viel zu teuer in Deutschland :eek::eek:

      Avatar
      schrieb am 16.05.06 17:55:14
      Beitrag Nr. 9 ()
      In Berlin hat auch nochmal einer zu 0,007 nachgelegt !
      Schaun wir mal :lick::lick:
      Avatar
      schrieb am 16.05.06 17:59:59
      Beitrag Nr. 10 ()
      mein english ist nicht so gut, kann mir bitte jemand in groben zügen sagen, was in den news steht ? danke euch im voraus
      Avatar
      schrieb am 16.05.06 18:10:45
      Beitrag Nr. 11 ()
      Antwort auf Beitrag Nr.: 21.609.197 von ollyh4 am 16.05.06 17:59:59Hier ein Überstzungsprogramm:

      http://world.altavista.com/
      Avatar
      schrieb am 16.05.06 18:23:20
      Beitrag Nr. 12 ()
      Parikurs 0,0057 :keks::keks:

      Noch stehen 610000 in Berlin zu 0,006 im BID - aber wie lange noch :confused:

      Denke man kommt in D auch zu 0,005 zum Zug


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      $$Global Matrechs +133%%%% in Berlin!!